VICTORIA, British Columbia (AP) _ Aurinia Pharmaceuticals Inc. (AUPH) on Tuesday reported a loss of $13.1 million in its third quarter.
On a per-share basis, the Victoria, British Columbia-based company said it had a loss of 16 cents.
The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 14 cents per share.
The biotechnology company posted revenue of $29,000 in the period, also falling short of Street forecasts. Four analysts surveyed by Zacks expected $130,000.
The company's shares closed at $5. A year ago, they were trading at $3.86.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AUPH at https://www.zacks.com/ap/AUPH